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The conformational nature of the B cell epitopes on the hepadnavirus surface antigens makes its characterization difficult.
Here, a new approach by DNA vaccination with plasmids expressing chimeric hepadnavirus surface antigens was explored
to determine B cell epitopes on the surface antigens of woodchuck hepatitis virus (WHsAg). A series of chimeric genes
consisting of complementary fragments of WHsAg and hepatitis B virus surface antigens (HBsAg) was constructed. These
plasmids expressed the following: (i) middle chimeric surface antigens (MCSAgs), including pre-S2 region and small surface
antigens; (ii) small chimeric surface antigens (CSAgs); (iii) a mutated WHsAg with two amino acid substitutions, the Leu 136
to Thr and Ala 140 to Asp, within the central immunogenic region. The mutated region from amino acid 135 to 143 within
WHsAg mimics the second loop of the HBsAg a-determinant. MCSAgs and CSAgs were expressed in transiently transfected
mammalian cells and were reactive to anti-HBsAg and anti-WHsAg, as shown by indirect immunofluorescence staining and
ELISA. Vaccination with plasmids encoding MCSAgs induced strong antibody responses to the pre-S2 region. Anti-pre-S2
antibodies were directed to a linear, immunodominant region within the amino-terminal region of the pre-S2 region and were
able to precipitate serum WHsAg. Vaccinations with the plasmids expressing the CSAgs led to the conclusion that an
extended region aa 116–169 of WHsAg, analogous to the HBsAg a-determinant, was sufficient for the induction of
anti-WHsAg antibodies. The mutated WHsAg with the second loop of the HBsAg a-determinant efficiently induced anti-
WHsAg antibodies, but also a low titer of anti-HBsAg. Thus, multiple B cell epitopes of a linear and conformational nature areINTRODUCTION
The envelope of hepatitis B virus (HBV) consists of
three proteins, large (L), middle (M), and small surface
antigen (HBsAg) (Stibbe and Gerlich, 1982; Heermann et
al., 1984). Small HBsAg is the major protein constituent of
the envelope of virion and subviral particles. It pos-
sesses a conformational, common B cell epitope called
the a-determinant, which includes the region aa 121–147
of the small HBsAg. This region is flanked by cysteine
residues, which are important to maintain the secondary
structure of this region and the antigenicity of HBsAg
(Imai et al., 1974; Mangold et al., 1995). An immunization
with HBsAg induces specific anti-HBsAg antibodies and
prevents HBV infection (Szmuness et al., 1981). Muta-
tions within the HBsAg a-determinant may reduce the
binding of anti-HBsAg antibodies and therefore contrib-
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342ute to immune escape and diagnostic failure (Carman et
al., 1990; Karthigesu et al., 1994; Ni et al., 1995; Carman,
1997; Chiou et al., 1997; Hsu et al., 1997; Grethe et al.,
1998; Ireland et al., 2000; Weinberger et al., 2000). The
HBsAg a-determinant has been mainly characterized by
using synthetic peptides, partly in cyclic forms mimicking
the secondary loop structures (Bhatanagar et al., 1985;
Brown et al., 1984; Dreesman et al., 1982; Gerin et al.,
1983; Irina et al., 1983; Ito et al., 1986; Lerner et al., 1981;
Neurath et al., 1984; Ohnuma et al., 1990). However, this
approach is difficult to apply for extended or complex
antigenic structures.
Woodchuck hepatitis virus (WHV) is a member of fam-
ily Hepadnaviridea and is genetically closely related to
HBV (Summers et al., 1978; Galibert et al., 1982). WHV
causes acute self-limiting and chronic infections in its
natural host eastern American woodchuck (Marmota
monax) that show a great similarity to HBV infection in
humans (Tennant and Gerin, 1994; Roggendorf and Tolle,
1995; Seeger and Mason, 1999; Lu and Roggendorf,present on WHsAg. We presented an efficient and broa
determinants of natural or mutated viral antigens. © 2002
strasse 55, 45122 Essen, Germany. Fax: 49 201 7235929. E-mail:
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2001). The WHV genome has a similar organization to the
HBV genome and four overlapping open reading framesdly ap
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encoding surface antigens, core and e-antigen, polymer-
ase, and X protein (Galibert et al., 1982). The major
surface antigen of WHV (WHsAg), the equivalent of
HBsAg, has a length of 222 aa residues and shows a
homology of 67–69% to HBsAg isolates and the conser-
vation of 12 cysteine residues. Immunizations with WH-
sAg induce anti-WHsAg antibody responses and lead to
protection against WHV challenge (Cote et al., 1986).
Chimpanzees immunized with WHsAg were partially pro-
tected against HBV infection, indicating that a cross-
reactivity of B or T cell responses to HBsAg and WHsAg
may exist. Yet, the B cell epitopes on WHsAg are not fully
characterized. The antibodies generated to native
WHsAg do not usually recognize denatured small
WHsAg in Western blotting, indicating that the dominant
antigenic determinants on WHsAg are of conformational
nature. Thus, such B cell epitopes on WHsAg cannot be
determined by using synthetic peptide panels. Based on
the reactivity of monoclonal antibodies to WHsAg, at
least five nonoverlapping antigenic sites exist on WHsAg
(Cote et al., 1982; Cote and Gerin, 1983). A series of
monoclonal antibodies (MAbs) showed cross-reactivity
to the surface antigen of ground squirrel hepatitis virus
(GSHV), while only one MAb recognized HBsAg with a
low avidity. The cross-reactivity of WHsAg specific MAbs
to HBsAg and GSHsAg reflects the antigenic relationship
between these antigens and is consistent with the se-
quence data.
In the present work, we took a new approach to de-
termine the B cell epitopes on WHsAg by using plasmids
encoding chimeric antigens of HBsAg and WHsAg
(CSAg) and by DNA immunization. DNA immunization is
a powerful method for the induction and modification of
specific immune responses (Michel et al., 1995; Davis et
al., 1996a,b; Schirmbeck et al., 1995, 2001; Donnelly et al.,
1997; Geissler et al., 1998; Lu et al., 1999). Since the
antigens are expressed in vivo and will be processed,
transported to their authentic cellular compartments, and
folded into their native conformations, DNA vaccine-
primed immune responses to an antigen closely reflect
the natural immunogenic properties of this antigen. In
this work, we demonstrated the usefulness of DNA im-
munization in combination with recombinant DNA tech-
nology for analysis of complex, conformational B cell
epitopes on WHsAg. We dissected the coding region of
WHsAg and HBsAg by PCR amplification and con-
structed a series of chimeric genes. Such chimeric
genes contained a part of WHsAg sequence and the
complementary HBsAg fragments and expressed CSAgs
in transiently transfected cells. Mice were immunized
with plasmids expressing CSAgs. The specificity of an-
tibody responses, in particular, those to the middle and
small surface antigens of WHV, was characterized. We
found that DNA immunizations induced a strong antibody
response to a linear, immunodominant epitope within the
amino-terminal part of the pre-S2 region of the middle
WHsAg (MWHsAg). The region aa 117–143 of WHsAg
corresponding to the HBsAg a-determinant was not suf-
ficient to induce an anti-WHsAg antibody response in
immunized mice. An extension of the WHsAg from aa
117–169 within the CSAg did improve the immunogenic-
ity of the CSAg, indicating this region forms a complex,
conformational B cell epitope. This strategy would be
useful for analysis of complex B cell epitopes, for exam-
ple, those on HBsAg escape mutants.
RESULTS
Construction of chimeric genes of HBsAg and WHsAg
Two groups of chimeric genes of HBsAg and WHsAg
were constructed in this study (Fig. 1). The HBV pre-S2 or
WHV pre-S2 region were included in plasmids pMCS1–
pMCS6. The coding sequences of pre-S2 aa 1–55 and
amino-terminal region aa 1–120 of HBsAg, a-determinant
aa 121–147, and carboxyl-terminal region aa 148–226 of
HBsAg were dissected by PCR cloning using primers
listed in Table 1. The three corresponding regions of
MWHsAg (WPre-S2 plus aa 1–116, aa 117–143, and aa
144–222) were obtained by the same strategy except the
primers (Table 1). pMCS1–pMCS6 were constructed by
ligation of complementary fragments encoding MHBsAg
and MWHsAg. In particular, pMCS5 encodes the sole
HBV a-determinant (aa 121–147) located in the context of
MWHsAg. In the plasmid pMCS6, aa 117–143 of WHsAg,
the corresponding part to HBsAg a-determinant, was
located in the context of MHBsAg. Two plasmids pMH-
BsAg and pMWHsAg that express the wild-type MHBsAg
and MWHsAg, respectively, were used for control immu-
nizations. In the second group, plasmids pCS1–pCS6,
the coding sequences for the pre-S2 region, were re-
moved. The control plasmids pHBsAg and pWHsAg ex-
press wild-type HBsAg and WHsAg, respectively. All
wild-type and chimeric genes were cloned into pcDNA3
or pcDNA3.1 and placed under the transcriptional control
of the CMV promoter.
Antigenicity of CSAgs
To examine the antigenicity of CSAgs, BHK cells were
transiently transfected with CSAg genes and the ex-
pressed CSAgs were detected by indirect immunofluo-
rescence (IF) staining using MAbs to HBsAg a-determi-
nant, polyclonal anti-HBsAg, and anti-WHsAg antibodies.
The results are summarized in Table 2 and Fig. 2.
CSAgs containing HBsAg a-determinant were recog-
nized by specific monoclonal and polyclonal anti-HBsAg
antibodies (Table 2). Particularly, the isolated HBsAg
a-determinant (aa 121–147) within the context of WHsAg
(MCSAg5 and CSAg5) retained the correct antigenicity.
Positive IF staining with a polyclonal goat anti-HBsAg
antiserum was observed in cells transfected with the
majority of these plasmids except pWHsAg, pCS1, pCS4,
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and pCS6 (Table 2). Thus, the polyclonal anti-HBsAg
appears to cross-react with the pre-S2 region of both
MHBsAg and MWHsAg, but did not recognize WHsAg.
Consistent with results of IF staining, the MCSAgs and
CSAgs containing the HBsAg a-determinant were de-
tected in the supernatant of transfected cells by HBsAg
immunoassay (Fig. 2).
Anti-WHsAg antibodies recognized the majority of
CSAgs expressed by transiently transfected cells (Table
2, Fig. 3). MCSAgs and CSAgs containing WPre-S2
and/or the region aa 117–222 were intensely stained by
anti-WHsAg antibodies. Rather unexpected, the MCSAg6
and CSAg6 containing aa 117–143 of WHsAg showed
only a weaker positive staining (Fig. 3). The CSAg3 and
CSAg5 containing aa 1–116 were also weakly stained by
anti-WHsAg, suggesting that minor epitopes may exist
within this region. The carboxyl-terminal part aa 144–222
of WHsAg in MCSAg2 and CSAg2 was not recognized by
anti-WHsAg in IF staining.
Taken together, MCSAgs and CSAgs containing the
HBsAg a-determinant showed the reactivity to anti-
HBsAg antibodies. At least two major antigenic sites on
WHsAg appeared to be located within the WPre-S2 and
the region aa 117–222.
Antibody responses to the pre-S2 region of MWHsAg
(WPre-S2) after DNA immunization with plasmids
expressing MCSAgs
To prove that the WPre-S2 region harbors major im-
munogenic sites, we asked whether DNA vaccination is
able to induce an antibody response to the WPre-S2
region. Plasmids pMWHsAg, pMCS3, pMCS4, and
pMCS5 encode MCSAgs with WPre-S2 (Fig. 1). After
immunizations with these four plasmids, mice developed
strong anti-WHsAg responses. In Western blotting, anti-
sera from these mice recognized a recombinant fusion
protein of glutathione-S-transferase (GST) and WPre-S2
(Fig. 4A). These sera showed no reactivity to GST (not
shown). Other plasmids did not induce antibodies to
WPre-S2 (Fig. 4A). The fine specificity of anti-WPre-S2
antibodies was analyzed in ELISAs with a panel of seven
FIG. 1. The structures of MCSAgs and CSAgs. White bars, parts derived from HBsAg; black bars, parts derived from WHsAg. The positions of
relevant amino acid residues of MHBsAg and MWHsAg are indicated. The a-determinant, aa 121–147 of HbsAg, and the corresponding region aa
117–143 of WhsAg, are indicated as well. The designations of plasmids encoding MHBsAg, MWHsAg, MCSAg 1–6, HBsAg, WHsAg, and CSAg 1–6
are given for each antigen.
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overlapping biotinylated peptides covering the entire
WPre-S2. Six anti-WPre-S2-positive sera S1–S6 from
mice immunized with pMWHsAg were tested using dif-
ferent peptides (Fig. 4B). Five sera were reactive to the
peptide aa 1–15, indicating that the amino-terminal part
of WPre-S2 contains an immunodominant B cell epitope.
One serum S6 showed a reactivity to the peptide aa
10–23. Other peptides aa 10–23, aa 18–31, and aa 26–39
were only recognized by individual sera in ELISAs. The
anti-WHsAg antibody response in sera from these mice
was predominantly of IgG2a subtype (data not shown).
These results indicate that the WPre-S2 region in the
wild-type MWHsAg and MCSAgs is highly immunogenic.
Further, we tested whether the WPre-S2-specific anti-
bodies are able to recognize serum WHsAg. A MAb
anti-WHs2.1 to WHsAg recognized the WPre-S2-derived
peptide aa 1–15, which contains an immunodominant
epitope (Fig. 4A). Anti-WHs2.1 was also reactive to se-
rum-derived WHsAg in ELISA (Fig. 4C). WHsAg fractions
were precipitated from woodchuck serum by using anti-
WHs2.1-coupled Sepharose 4B. These fractions con-
sisted of multiple proteins of 27–29, 45, 51, and 55 kDa
that correspond to the components of purified WHsAg
particles of small, middle, and large WHsAg (Fig. 4D).
Collectively, the WPre-S2-specific MAb was able to rec-
ognize serum WHsAg, suggesting that WPre-S2 specific
antibodies may potentially contribute to the clearance of
viral antigens.
TABLE 1
Primers for Constructing Chimeric Genes of HBsAg and WHsAg
Designation Polarity Sequence Position of 5 base Position of mutations
HBs-55 Sense ATCCTCAGGCCATGCAGTGG 3163a
HBSATG Sense GCGCTGAACATGGAGAACATCAC 157a
HBs120a Antisense CTGCAATTGCCCGTGCTGGTAGTTG 521a 516–513a
HBs121s Sense CGGGCAATTGCAGAACCTGCATGACT 509a 513–516a
HBs148s Sense ATTGCACGTGTATTCCCATCCC 593a 600a
HBs147a Antisense ATACACGTGCAATTTCCGTCCG 605a 600a
HBsstop Antisense CCATCTTTTTGTTTTGTTAGGG 860a
Wpres2 Sense CAGTTAACTATGAAAAATCAGAC 107b
WSATG Sense ACCGGAGATGTCACCATCAAGTC 289b
WHs117s Sense CAGTCAATTGCAGACAATGC 636b
WHs116a Antisense GTCTGCAATTGACTGTGTTGTTTC 650b
WHs144s Sense ATTGCACGTGTTGGCCCATC 720b 727b
WHs143a Antisense CCAACACGTGCAATTTCCTGCC 733b 727b
Wsp2 Antisense CCACCATTTTGTTTTATTAA 987b
IF Sense CCCATCCCTTCATGGGCTTTCGGAAA 734b 757b
IR Antisense TTTCCGAAAGCCCATGATGAAGGGATGGG 762b 757b
FKFSF Sense CCTATGGGAGTGGGCCTTAGCCCGTTTCTC 766b
FKFSR Antisense GAGAAACGGGCTAAGGCCCACTCCCATAGG 795b
pmS5 Sense ACTGTTGTTGTACAAAACCTACGGATGGAAATT 690b 701/702/714/715b
pmS6 Antisense GTGCAATTTCCATCCGTAGGTTTTGTACAACAA 726b 701/702/714/715b
Note. Bold letters indicate that the bases were mutated to create restriction sites or to introduce amino acid substitutions. The restriction sitesMunI
(CAATTG) and BbrpI (CACGTG) in the primers are underlined.
a The numbering of the HBV genome is according to Stoll-Becker et al. (1997).
b The numbering of the WHV genome is according to Galibert et al. (1982).
TABLE 2
Immunofluorescence Staining of Wild Type and Chimeric Surface
Antigens with Anti-HBsAg and Anti-WHsAg Antibodies
Antibodies for immunofluorescence staining
MAb to the HBsAg
a-determinant
Polyclonal
anti-
HBsAg
Polyclonal
anti-
WHsAg
Antigens
MHBsAg   
MWHsAg   
MCSAg1   
MCSAg2   
MCSAg3   
MCSAg4   
MCSAg5   
MCSA6   
SHBsAg   
SWHsAg   
CSAg1   
CSAg2   
CSAg3   
CSAg4   
CSAg5   
CSAg6   
Mock   
Note. Monoclonal anti-HBsAg (Biotrend or Dako), polyclonal anti-
HBsAg (Biotrend), and a rabbit anti-WHsAg IgG were used for immu-
nofluorescence staining. , strong IF staining, as seen for the wild-
type HBsAg or WHsAg; , weak staining; , no specific staining.
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A region comprising the aa 117–169 of WHsAg was
able to induce anti-WHsAg antibody
The HBsAg a-determinant aa 121–147 is immunodom-
inant and showed a proper immunogenicity in context of
CSAgs (Schirmbeck et al., 2001). We asked whether the
corresponding region aa 117–143 of WHsAg is able to
induce a specific antibody response. Rather unexpect-
edly, no anti-WHsAg response was induced in mice by
vaccination with pCS6 containing aa 117–143 of WHsAg
(Figs. 5A and 5C). Since the region aa 117–222 of WHsAg
has been shown to be able to induce an anti-WHsAg
antibody response, an additional sequence to aa 117–
143 of WHsAg may be required for the restoration of the
immunogenicity of this region (Schirmbeck et al., 2001).
To map the complete B cell epitope between the aa 117
and 222 of WHsAg, two plasmids pCS610 and
pCS626 were constructed, encoding CSAg containing
aa 117–153 and aa 117–169 of WHsAg, respectively (Fig.
5A). The expression of CSAgs was detected in transiently
transfected BHK cells. While pCS610 transfected cells
showed only a weak IF staining with anti-WHsAg anti-
body, strong IF staining was seen in pCS626 trans-
fected cells similar to that seen in wild-type WhsAg-
transfected cells (Fig. 5B, staining of wild-type WHsAg
not shown). Apparently, the addition of 26 amino acid
residues to the carboxyl-terminal end of the putative
“a-determinant” was necessary to the proper antigenic
structure of WHsAg. No significant differences in anti-
WHsAg titers were observed between mice immunized
with plasmids pCS6 and pCS610, while pCS626 in-
duced a significantly higher anti-WHsAg antibody re-
sponse (Fig. 5C). CSAg with the carboxyl-terminal region
147–222 aa failed to induce a WHsAg-specific antibody
response in mice (data not shown).
Conversion of the WHsAg aa 135–143 to the second
loop of the HBV a-determinant by site-directed
mutagenesis
The second loop of the HBV a-determinant is sup-
posed to be important for the recognition of anti-HBsAg
antibodies (Carman, 1997). Mutations within the second
loop of the HBsAg a-determinant such as Gly 145 to Arg
significantly impede the binding of antibodies to HBsAg
and may therefore lead to immune escape (Carman et
al., 1990; Karthigesu et al., 1994; Ni et al., 1995; Chiou et
al., 1997; Hsu et al., 1997; Grethe et al., 1998; Ireland et
al., 2000). Two amino acid substitutions Leu 136 to Thr
and Ala 140 to Asp were introduced into WHsAg, result-
ing in the expression vector pWH6K5 (Fig. 6A). The re-
gion aa 135–143 of WHsAg harboring these two amino
acid substitutions mimics the second loop of the HBsAg
a-determinant and allowed the study of the ability of this
region to induce a specific antibody response. WHsAg
was detected by IF with polyclonal anti-WHsAg and one
FIG. 3. IF staining with anti-WHsAg antibody of BHK cells transfected
with pcDNA3 (A), pWHsAg (B), and pMCS6 (C). Magnification, 400.
pMWHsAg encoded MWHsAg, while a CASg containing only the region
aa 117–143 of WHsAg was expressed by pMCSVI.
FIG. 2. Detection of MHBsAg, HBsAg, MCSAgs, and CSAgs by
HBsAg-specific ELISA. Supernatants of BHK cell-transfected plasmids
expressing wild-type or chimeric surface antigens were collected 48 h
after transfection and tested in a commercial ELISA (DiaSorin). The
cutoff of the ELISA is OD450  0.07.
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selected monoclonal antibody to HBsAg a-determinant in
transiently transfected BHK cells (Fig. 6B). Immunizations
of five mice with plasmid pWH6K5 led to the develop-
ment of different titers of anti-WHsAg antibody responses
in mice (Fig. 6C) and a low level of anti-HBsAg antibodies
in one mouse (Fig. 6D). Thus, the second loop of the
HBsAg a-determinant was immunogenic but not domi-
nant in the context of WHsAg.
DISCUSSION
By using chimeric antigens and DNA immunization, we
were able to selectively prime specific B and CTL re-
sponses to HBsAg and study their role in the clearance
of HBsAg in previously transgenic mice (Schirmbeck et
al., 2001). Here, we analyzed complex B cell epitopes on
WHsAg by exploring this strategy. This strategy is effi-
cient since time-consuming procedures for the expres-
sion and the purification of naive antigens is not neces-
sary. In addition, the immune response to antigens pro-
duced by host cells by DNA vaccination closely reflects
the natural situation. An interesting application will be
the characterization of immunological properties of
HBsAg escape mutants (Wu et al., 1999).
B cell epitopes on WHV surface antigens
At least two major B cell epitopes exist on MWHsAg,
as follows: (i) the WPre-S2 region contains one immuno-
dominant B cell epitope and several minor epitopes; (ii)
another epitope corresponding to HBsAg a-determinant
was located within the central region around aa 117–169
of WHsAg. In homology to HBsAg, the WPre-S2 region
and the region aa 117–169 of WHsAg are likely exposed
on virions or subviral particles and therefore represent
primary targets of the antibody response. A schematic
FIG. 4. The antibody response to the WPre-S2 region. (A) Detection of anti-WPre-S2 antibodies by Western blotting to the GST-Wpre-S2 fusion
protein. GST-WPre-S2 fusion protein was blotted onto a nitrocellulose sheet. A WHV PreS2-specific monoclonal antibody anti-WHs 2.1 (lane 1) and
1:200 diluted antisera from mice immunized with pMWHsAg (lane 2) or pMCS1–pMCS6 plasmids (lanes 3–8) were tested for their reactivity to the
WPreS-GST fusion protein on the nitrocellulose sheet. (B) Determination of the fine specificity of anti-WPre-S2 antibody responses by ELISA with
peptides. A monoclonal antibody WHs2.1 to WPre-S2 and six anti-WPre-S2 positive sera S1–S6 from mice immunized with pMWHsAg were tested for
their reactivity to seven biotinylated peptides derived from the sequences of the WHV pre-S2 region in ELISA. An anti-WPre-S2 negative mouse serum
(neg) was used as control. (C) The reactivity of a monoclonal antibody anti-WHs2.1 to serum WHsAg. Anti-WHs 2.1 or a mouse monoclonal antibody
to hMHC-I as control were coated to microtiter plates at a concentration of 1 g per ml. After blocking with FCS (5% in PBS), WHsAg-positive
woodchuck sera were added to plates at a dilution of 1:50. The bound WHsAg was detected by horseradish peroxidase conjugated rabbit anti-WHsAg.
(D) Precipitation of serum WHsAg by anti-WHs2.1. WHsAg fractions were precipitated by affinity chromatography using an anti-WHs2.1-coupled
Sepharose 4B column and subjected on Coomassie-stained SDS–PAGE. M, Prestained broad range protein marker (New England Biolabs,
Hertfordshire, U.K.).
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description of the B cell epitopes on WHsAg is presented
in Fig. 7.
We previously found that plasmids expressing CSAgs
containing the aa 121–147 of HBsAg were able to effi-
ciently induce anti-HBsAg antibodies. However, the cor-
responding region on WHsAg did not show the same
high immunogenicity. An extension of 26 amino acid
residues to the carboxyl-terminal region restored the
ability of the CSAg to induce an anti-WHsAg antibody
response. Thus, the entire extracellular region aa 121–
169 of WHsAg is important for the immunogenicity. Anal-
ogous to HBsAg, conformational or discontinuous B cell
epitopes are probably formed. Compared with HBsAg,
the region aa 148–169 of WHsAg contains only a few
amino acid substitutions at aa 146 Trp, aa 154 Leu, aa
155 Gly, aa 156 Asn, and aa 157 Tyr. According to the
current model, these amino acid residues are located at
the exposed position of surface antigens and therefore
may directly contribute to the immunogenicity (Chen et
al., 1996). The corresponding region of HBsAg contains
sites for the recognition by specific monoclonal antibod-
ies to HBsAg (Chen et al., 1996). Cote et al. showed that
the surface antigen of ground squirrel hepatitis virus
(GHVsAg) and WHsAg share a number of antigenic
epitopes (Cote et al., 1982; Cote and Gerin, 1983). GHsAg
shows several amino acid substitutions to WHsAg within
the region of aa 121–169. However, the positions of these
amino acid substitutions showed variations even be-
tween different HBV subtypes and may be not critical for
the immunogenicity.
FIG. 5. Mapping of the immunogenic determinant aa 114–169 on WHsAg. (A) The amino acid sequence of the HBsAg a-determinant and the
corresponding region of WHsAg. The WHsAg sequences were extended from aa 114 to aa 153 and aa 169 in chimeric antigens encoded by plasmids
pCS610 and pCS626, respectively. (B) Immunofluorescence staining with anti-WHsAg antibodies of BHK cells transfected with pCS6, pCS610,
and pCS626. Magnification, 400. (C) Anti-WHsAg antibody response in mice immunized with pWHsAg, pCS6, pCS610, and pCS626.
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The significance of antibody response to the pre-S2
region of hepadnavirus antigens
The pre-S2 region of both MHBsAg and MWHsAg
induces strong antibody responses in DNA-immunized
mice. The significance of the anti-pre-S2 antibody re-
sponse for virus clearance or for protection in HBV in-
fection has been examined in several early studies. Anti-
pre-S2 antibodies were detected in HBV-infected pa-
tients or in persons vaccinated with plasma-derived
HBsAg (Alberti et al., 1988; Budkowska et al., 1992; Cour-
saget et al., 1988). An association of the anti-pre-S2
antibody response and virus clearance was proposed.
Itoh et al. (1986) reported that vaccination of chimpan-
zees with a synthetic peptide aa 14–32 of HBV pre-S2
region induced antibodies to HBV particles and pro-
tected these animals from virus challenge. We demon-
strated previously that a transfer of the B cell response to
the pre-S2 of MHBsAg cleared circulating HBsAg from
the periphery in transgenic mice (Schirmbeck et al.,
2001). Similarly, we showed here that serum WHsAg
could be precipitated by anti-WPre-S2 antibodies. There-
fore, antibody responses directed to the pre-S2 region
may significantly contribute to control of hepadnavirus
infection. Further immunization experiments with recom-
FIG. 6. Introduction of mutations Leu 136 to Thr and Ala 140 to Asp into WHsAg. (A) The amino acid sequences of the region aa 121–147 of HBsAg,
aa 117–143 of WHsAg, and aa 117–143 of the mutant sequence WHsAg6K5. Two amino acid residues of WHsAg were substituted: Leu 136 to Thr and
Ala 140 to Asp. These amino aid substitutions created a sequence corresponding to the second loop of HBsAg a-determinant. (B) Detection of mutated
WHsAg6K5 by IF staining with a monoclonal antibody to HBsAg a-determinant. The mutated WHsAg was expressed in BHK cells by transient
transfection. IF staining was performed for transfected cells with a monoclonal antibody to HBsAg a-determinant. (C and D) Five mice were immunized
three times with 100 g of plasmid pWHsAg6K5. The anti-WHsAg (C) and anti-HBsAg (D) responses induced by pWHsK6 were determined in ELISA
for anti-WHsAg and anti-HBsAg.
FIG. 7. A schematic description of the identified epitopes on WHsAg
for antibody recognition. The positions of relevant amino acid residues
of MWHsAg are indicated. The region aa 117–169, the equivalent on
WHsAg to the HBsAg “a-determinant,” is indicated as well. Gray bars
indicate the regions on WHsAg that are recognized by anti-WHsAg
antibodies in IF and ELISA assays. White bars indicate the regions on
WHsAg that are able to efficiently induce specific antibody responses.
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binant WHV pre-S proteins in the woodchuck model will
clarify the role of anti-WPre-S2 antibodies in protection
against WHV infection.
While a weak cross-reactivity of polyclonal anti-HBsAg
antibodies to the preS2 of MHBsAg was observed, the
anti-WPreS2 antibodies were not reactive with HBV
preS2. Consistently, a transfer of splenocytes from prior
immunized mice with MWHsAg into HBsAg-transgenic
mice did not show any effect on circulating HBsAg con-
centration (our unpublished data). This fact may be ex-
plained by the difference in the immunodominant regions
of HBV pre-S2 (aa 14–32) and WPre-S2 (aa 1–15).
Cross-reactivity anti-HBsAg and anti-WHsAg
antibodies
In early studies, cross-reactivity between anti-HBsAg
and anti-WHsAg was observed (Werner et al., 1979; Fei-
telson et al., 1981; Stannard et al., 1983). In particular, a
monoclonal antibody to WHsAg was able to recognize
HbsAg, even though its affinity to HBsAg appeared to be
low (Cote and Gerin, 1983). However, the cross-reactivity
of anti-surface antibodies appeared to be directed to
minor epitopes and could not be determined by ELISAs
or immunoprecipitation. Consistently, an adoptive trans-
fer of B cell responses to WHsAg into HBsAg-transgene
mice did not lead to the clearance of HBsAg from the
periphery (our unpublished observations). Thus, those
cross-reactive antibodies, although they exist, may be
immunologically ineffective.
The significance of the second loop of the HBsAg
a-determinant for the immunogenicity
The second loop of HBsAg a-determinant is supposed
to be critical for the proper antigenicity and immunoge-
nicity of HBsAg. CSAgs with the sole second loop of
HBsAg a-determinant could be recognized in indirect IF
by monoclonal antibodies specific for the HBsAg a-de-
terminant. However, only one of five mice immunized
with the plasmid showed a measurable anti-HBsAg an-
tibody response. A mutant of the infectious clone WHV8
with both aa substitutions Leu 136 to Thr and Ala 140 to
Asp of WHsAg was constructed and injected in circular
form into liver of woodchucks. One woodchuck devel-
oped an acute self-limiting infection and a low level of
viremia. However, surface antigens could be detected in
WHsAg ELISA but not in HBsAg ELISA. Interestingly,
anti-HBsAg antibodies were detected in woodchuck sera
at low levels (our unpublished observation). These re-
sults indicate that the second loop of the HBsAg a-de-
terminant is able to induce an HBsAg-specific antibody
response but only with a low efficiency in the context of
the flanking WHsAg sequence. It is likely that the con-
formation of the region aa 117–143 of WHsAg is different
from the HBsAg a-determinant.
MATERIALS AND METHODS
Antigen-encoding plasmid DNA used for nucleic acid
vaccination
The coding regions of MHBsAg (subtype adw) and
MWHsAg (subtype WHV8) were dissected by PCRs us-
ing primers in Table 1, as follows: HBsAg 55/120 with
primers HBs-55/HBs120a, HBsAg 55/147 with HBs-55/
HBs147a, HBsAg 121/226 with HBs121a/HBsstop, HBsAg
148/226 with HBs148a/HBsstop, HBs 121/147 with
HBs121s/HBs147a, WHsAg 117/222 with WHs117s/
Wsp2, WHsAg 144/222 with WHs144s/Wsp2, WHsAg
60/116 with WpreS2/WHs116a, WHsAg 60/143 with
WpreS2/WHs143a, and WHsAg 117/143 with WHs117s/
WHs143a. Sequences of eight primers were modified to
create MunI and BbrpI sites for the construction of chi-
meric MHBsAg/MWHsAg genes. PCR fragments were
cloned into pCR2.1 according to the manufacturer’s in-
structions. The cloned fragments were subjected to DNA
sequencing analysis to verify the correctness of the se-
quences. These fragments were recloned into pcDNA3
at the restriction sites HindIII and XhoI. Six chimeric
genes of MHBsAg and MWHsAg were constructed by
ligation of fragments as listed in Fig. 1, as follows:
pMCS1 with HBsAg 55/120 and WHsAg 117/222,
pMCS2 with HBsAg 55/147 and WHsAg 144/222,
pMCS3 with WHsAg 60/143 and HBsAg 148/226,
pMCS4 with WHsAg 60/143 and HBsAg 147/226,
pMCS5 with WHsAg 60/116, HBsAg 120/147, and
WHsAg 144/222 and pMCS6 with HBsAg 55/120,
WHsAg 117/143, and HBsAg 148/226. The fragments
were ligated either by the MunI site at the junction
120/121 or by the BbrpI site at the junction 147/148
(numbering according HBsAg). In the generated plasmid
constructs the antigens are expressed under control of
the human CMV immediate early promoter.
A corresponding set of plasmids, pHBsAg, pWHsAg,
pCS1–pCS6 without the HBV or WHV pre-S2 region, was
constructed on the basis of pMWHsAg, pMHBsAg, and
pMCS1–pMCS6. Two additional sense primers HBSATG
and WSATG in combination with antisense primers Wsp2
and HBsstop were used for PCR amplification of corre-
sponding chimeric s genes. PCR products were directly
cloned into pCR3.1 vector according to the manufactur-
er’s instructions.
pCS6 was modified to contain WHV sequences nts
636–762 and 636–795, resulting in plasmids pCS610
and pCS626, respectively. These plasmids expressed
chimeric proteins with WHV-specific sequences aa 117–
153 and 117–169 with flanking HBsAg sequences, re-
spectively. Site-directed mutagenesis PCR was used for
constructing these plasmids. Two pairs of primers which
completely matched each other were designed: sense
primers IF and FKFSF and antisense primers IR and
FKFSR. Two different products of first PCR were pro-
duced using pCSI as templates with the sense primer
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HBSATG and antisense primers IR and FKFSR, respec-
tively. Complementary, two other products of first PCR
were produced using pHBsAg as templates with the
antisense primer HBsstop and sense primers IF and
FKFSF, respectively. Mixtures of complementary prod-
ucts of first PCR were mixed in a 1:1 ratio and subjected
to the second PCR with primers HBsATG and HBsstop.
The PCR products were cloned into pCR3.1 vector (In-
vitrogen) to generate plasmids pCS610 and pCS626.
The correctness of their sequences was verified by se-
quencing of the plasmids.
Four mutations T–A at nt 101, T–C at nt 102, C–A at nt
114, and A–T at nt 115 were introduced into the WHV s
gene by PCR mutagenesis using primers psm5 and
psm6 (Table 1). This procedure resulted in an expression
plasmid pWH6K5 that expressed WHsAg with two muta-
tions Leu 136 to Thr and Ala 140 to Asp (WHsAg6K5).
Transient transfection with the expression plasmids
BHK cells (105 per well) were maintained in Eagle’s
MEM supplemented with 10% FCS in a two-well tissue
culture chamber slide at 37°C and 5% CO2 until the cells
reached approximately 50–80% confluence. Eight micro-
grams of DNA plasmid and 8 l Lipofectamine (GIBCO
BRL, Neu-Isenburg, Germany) were diluted with 72 l
OPTI-MEM, respectively, and then mixed. Following
30–45 min incubation at room temperature, DNA–lipo-
some complexes were diluted in 640 l OPTI-MEM and
slowly added to prewashed cells. The DNA–liposome
complexes were removed after 6-h incubation at 37°C
and 5% CO2. Two milliliters of fresh MEM containing 10%
FCS was added to cells and incubation was continued
for 42 h. Supernatants from each well were collected and
stored at 20°C for detection of HBsAg. Transfected
BHK cells were washed twice with phosphate-buffered
saline (PBS) and fixed with 50% methanol at 4°C for 30
min for immunofluorescence staining.
Indirect immunofluorescence staining of transfected
BHK cells
Polyclonal rabbit anti-WHsAg (prepared by our lab,
1:20 dilution with PBS), polyclonal goat anti-HBs raised to
plasma-derived HBsAg (Biotrend, Ko¨ln, Germany, 1:40
dilution with PBS), and monoclonal mouse anti-HBsAg “a”
antibodies (Biotrend or Dako, Hamburg, Germany, 1:100
dilution with PBS) were used as first antibodies for IF
staining. An amount of 400 l of diluted antibodies was
added into each well. After incubation 1 h at 37°C, cells
were washed with PBS three times. Anti-rabbit-IgG FITC
(1:200 dilution), anti-goat-IgG FITC (1:400 dilution), or
anti-mouse-IgG FITC (1:200 dilution) were used as sec-
ond antibodies. All of the second antibodies were diluted
with PBS and contained 0.1% Evans blue and incubated
at 37°C for 1 h. Thereafter, cells were washed with PBS
and covered with mounting medium (Lu et al., 1999).
HBsAg ELISA
A commercial HBsAg ELISA kit (DiaSorin, Saluggia,
Italy) was used for detection of chimeric surface proteins
in culture supernatants of transfected cells according to
the manufacturer’s instructions.
DNA-based immunization of mice
BALB/cJ (H-2d) mice were kept under standard patho-
gen-free conditions in the animal center of the University
of Essen. Adult mice were immunized intramuscularly
(i.m.) into the musculus tibialis anterior with 100 g
plasmid DNA as described previously (Schirmbeck et al.,
1995, 2001).
Detection of antibodies to the pre-S2 region of
MWHsAg
The WHV genome region nt 1–298 comprising the
pre-s2 was cloned at EcoRI and XhoI sites of the pGEX-
4T-2 vector (Pharmacia, Freiburg, Germany), resulting a
plasmid pGST-WPreS2. A fusion protein consisting of
GST and the WPre-S2 region of MWHsAg was expressed
by Escherichia coli harboring pGST-WPreS2 and used for
detection of anti-WPre-S2 antibodies by Western blotting.
In addition, a set of biotinylated synthetic peptides cov-
ering the pre-S2 region of MWHsAg was purchased from
EMC Microcollection GMbH (Tu¨bingen, Germany): MKN-
QTFHLQGFVDGL (aa 1–15), GFVDGLRDLTTTER (aa 10–
23), LTTTERQHNAYRDP (aa 18–31), NAYRDPFTTLSPAV
(aa 26–39), TLSPAVPTVSTILS (aa 34–47), VSTILSPPSTT-
GDP (aa 42–55), and STTGDPALSPEMSPS (aa 50–64).
The peptides at a concentration of 1 g per ml PBS were
added to streptavidin-coated microplates (Roche Diag-
nostics, Mannheim, Germany). After 1 h incubation at
37°C, the microplates were washed three times. Sera
samples from immunized mice at a dilution of 1:50 were
added to the plates. Bound antibodies were detected by
an anti-mouse IgG horseradish peroxidase conjugates
(Sigma, Deisenhof, Germany).
Detection of specific anti-HBsAg and anti-WHsAg
antibodies by ELISA
Anti-HBs antibodies in serum samples were detected
by Enzygnost anti-HBs II kit (Behring, Marburg, Germany)
according to the manufacturer’s instructions. Anti-
WHsAg antibodies were detected by the following pro-
tocol: the plates were coated overnight with 1 g WHsAg
per ml in 0.1 M carbonate buffer, (pH 9.6) at 4°C, blocked
with 100 l of 5% FCS for 1 h at 37°C. Fifty microliters of
mouse serum samples at dilutions 1:10–1:1000 was dis-
pensed into the wells and incubated at 37°C for 1 h. After
washing, 50 l horseradish peroxidase conjugated rab-
bit anti-mouse IgG at a dilution of 1:1000 was added into
each well for 1 h at 37°C. Fifty microliters of dissolved
OPD was added as the substrate of horseradish perox-
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idase into the wells. The development of color occurred
at room temperature and was read at 490 nm. The cut-off
value was set as three times over negative controls. The
antibody IgG subtypes were detected by using specific
horseradish peroxidase conjugated monoclonal antibod-
ies to mouse IgG1 and IgG2a.
Purification of WHsAg by affinity chromatography
WHs2.1, a monoclonal anti-WHs antibody, was gener-
ated previously (Waters et al., 2001). Ten milligrams of the
purified antibody was coupled with 1.5 g cyanogen bro-
mide activated Sepharose 4B (Pharmacia Biotech) in
coupling buffer [0.1 M sodium bicarbonate (pH 8.3) con-
taining 0.5 M sodium chloride] overnight. After washing
according to the manufacturers instructions, a column
was packed. Five milliliters of serum from a woodchuck
chronically infected with WHV was diluted in PBS and
recirculated through the anti-WHs affinity column for
16 h. The column was washed and the WHsAg eluted
with 3 M potassium iodide. The antigen was concen-
trated and returned to PBS buffer by diafiltration. Twenty
microliters of the purified antigen was analyzed after
reduction by boiling for 5 min with 5% 2-mercaptoethanol
on a 10% SDS–PAGE gel.
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